Aptahem enters collaboration agreement with Granzer Regulatory Consulting and Services to prepare for clinical stage

Aptahem AB (publ), announce today that the company enters a collaboration agreement with the German company Granzer Regulatory Consulting and Services to prepare for applications to the European Medicines Agency (EMA) and the Food and Drug Administration (FDA). Granzer...

Read More

BioStock article: Aptahem’s founder is back – now as Chairman of the Board

BioStock published an article on 15 October 2020 about Aptahem, which can be read in full below. On September 25, Bert Junno was elected Chairman of the Board of the biotech company Aptahem. As a founder of several companies...

Read More